BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1739624)

  • 21. Bone marrow examination in Hodgkin's disease.
    Abrahamsen AF; Jakobsen E; Langholm R; Abrahamsen JF; Kvaløy S; Nome O
    Acta Oncol; 1992; 31(1):41-2. PubMed ID: 1586503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow cellularity MRI calculation and correlation with bone marrow biopsy.
    Matcuk GR; Siddiqi I; Cen S; Hagiya A; Isaacson R; Brynes R
    Clin Imaging; 2016; 40(3):392-7. PubMed ID: 27133674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does magnetic resonance imaging give value-added than bone scintigraphy in the detection of vertebral metastasis?
    Chiewvit P; Danchaivijitr N; Sirivitmaitrie K; Chiewvit S; Thephamongkhol K
    J Med Assoc Thai; 2009 Jun; 92(6):818-29. PubMed ID: 19530588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of fat content in vertebral marrow using a modified dixon sequence to differentiate benign from malignant processes.
    Yoo HJ; Hong SH; Kim DH; Choi JY; Chae HD; Jeong BM; Ahn JM; Kang HS
    J Magn Reson Imaging; 2017 May; 45(5):1534-1544. PubMed ID: 27690264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of bone marrow involvement in Hodgkin's lymphoma on first presentation.
    Nadeem M; Naqi N; Hussain I; Khattak J; Ahmed R; Khan B
    J Coll Physicians Surg Pak; 2009 Dec; 19(12):768-71. PubMed ID: 20042154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign versus pathologic compression fractures of vertebral bodies: assessment with conventional spin-echo, chemical-shift, and STIR MR imaging.
    Baker LL; Goodman SB; Perkash I; Lane B; Enzmann DR
    Radiology; 1990 Feb; 174(2):495-502. PubMed ID: 2296658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging of the bone marrow in lymphomas and leukemias.
    Tardivon AA; Vanel D; Munck JN; Bosq J
    Leuk Lymphoma; 1997 Mar; 25(1-2):55-68. PubMed ID: 9130614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma--a second look.
    Ebie N; Loew JM; Gregory SA
    Hematol Pathol; 1989; 3(1):29-33. PubMed ID: 2745358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repopulation of marrow after transplantation: MR imaging with pathologic correlation.
    Stevens SK; Moore SG; Amylon MD
    Radiology; 1990 Apr; 175(1):213-8. PubMed ID: 2315483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging of the bone marrow in patients with leukemia, aplastic anemia, and lymphoma.
    Olson DO; Shields AF; Scheurich CJ; Porter BA; Moss AA
    Invest Radiol; 1986 Jul; 21(7):540-6. PubMed ID: 3460974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's disease.
    Seymour LK; Dansey RD; Bezwoda WR
    Br J Cancer; 1994 Sep; 70(3):526-30. PubMed ID: 8080741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
    Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN
    J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [MR tomography detection of bone marrow infiltration by malignant lymphomas].
    Gückel F; Döhner H; Knauf W; Ho AD; Semmler W; van Kaick G
    Onkologie; 1989 Aug; 12 Suppl 1():34-7. PubMed ID: 2685693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
    Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic importance of magnetic resonance imaging in bone marrow involvement of Hodgkin disease.
    Varan A; Cila A; Büyükpamukçu M
    Med Pediatr Oncol; 1999 Apr; 32(4):267-71. PubMed ID: 10102020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lumbar spondylolysis: reactive marrow changes seen in adjacent pedicles on MR images.
    Ulmer JL; Elster AD; Mathews VP; Allen AM
    AJR Am J Roentgenol; 1995 Feb; 164(2):429-33. PubMed ID: 7839983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation.
    Griffith JF; Yeung DK; Antonio GE; Wong SY; Kwok TC; Woo J; Leung PC
    Radiology; 2006 Dec; 241(3):831-8. PubMed ID: 17053202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bone marrow changes in Hodgkin's disease: MR tomography and chemical shift imaging].
    Gückel F; Semmler W; Brix G; Bachert-Baumann P; Körbling M; Bihl H; van Kaick G
    Rofo; 1989 Jun; 150(6):670-3. PubMed ID: 2544941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and late bone-marrow changes after irradiation: MR evaluation.
    Stevens SK; Moore SG; Kaplan ID
    AJR Am J Roentgenol; 1990 Apr; 154(4):745-50. PubMed ID: 2107669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.